What happened
Abiomed (NASDAQ:ABMD) stock jumped 10.6% in September, according to data fromS&P Global Market Intelligence. For context, theS&P 500 returned0.6% last month.
Shares of the minimally invasive heart pump maker, however, have given back those gains already in October. Through Oct. 10, the stock is down 16.6%. Unlike last month’s movement, which was due to company-specific news, this month’s sell-off appears to be a casualty of the broader market’s struggles. The S&P 500 and the tech-heavy Nasdaq Composite are in the red 4.4% and 7.8%, respectively,....More>>>